ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996

Former NCI Lab Deputy Charged With Two Criminal Counts

January 17, 1992

NCI Cooperative Group Clinical Trials Listed

April 24, 2009

Funding opportunities listed.

October 29, 2004

NCI Advisory Group, Other Cancer Meetings For Oct., Nov., Future

September 28, 1990

Cancer Meetings Listed

October 24, 1997